Why the study?
The study was conducted to compare heart, LV, and coronary artery dose-sparing between 3D-CRT and HT in patients with left-sided breast cancer.
Does helical tomotherapy improve target coverage and reduce cardiac radiation dose compared to 3D-CRT in patients with left-sided breast cancer?
Does helical tomotherapy improve target coverage and reduce cardiac radiation dose compared to 3D-CRT in patients with left-sided breast cancer?
Helical tomotherapy improves target coverage and reduces radiation dose to the left ventricle and left anterior descending artery in left-sided breast cancer, potentially lowering the risk of radiation-induced cardiotoxicity.
HT planning may improve cardiac sparing in left BC; leaves open clinical benefit versus 3D-CRT.
BACKGROUND/AIM: To compare heart, left ventricle (LV) and coronary artery dose-sparing with three-dimensional conformal radiotherapy (3D-CRT) vs. helical tomotherapy (HT) in left-sided breast cancer (BC). PATIENTS AND METHODS: 3D-CRT and HT treatments were planned for 20 patients (pts). Computed tomography (CT) scans without and with intravenous contrast (ic) were performed and co-registered. Left breast and organs at risk (OARs) were contoured. Dose-volume histograms (DVHs) for 3D-CRT and HT treatment plans were evaluated in terms of planning target volume for evaluation (PTVeval) coverage and dose to the OARs. RESULTS: HT provided the best target coverage and significantly reduced D2% and mean dose to the left anterior descending artery (LADA) and to the LADA-planning organ at risk volume (PRV), D2%, V5 and mean dose to the LV and D2% and V25 to the heart. As expected, due to the rotational delivery, the dose to all other coronary arteries and their PRV, contralateral breast and lungs was higher with HT. CONCLUSION: In left-sided BC, HT provided the best target coverage and significantly reduced LV and LADA doses. Moreover D2% and V25 to the heart were significantly reduced. Further studies are needed to correlate dosimetric findings with in-depth cardiac monitoring.
No takes yet. Share an insight, caveat, or question.
Palumbo et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: